Avexima Innotech Company is implementing a strategic project aimed at ensuring Russian drug safety at the Russky Innovation Scientific and Technological Center in Vladivostok, according to a statement from the press service of Yury Trutnev, the Russian Presidential Envoy to the Far Eastern Federal District.
“The project involves the creation of an R&D center and a pilot production facility for a reverse-engineering program of vital medicines. The focus will be on developing Russian versions of four critically important drugs for the treatment of cancer, cardiovascular diseases, and diabetes. The cost of the drugs is expected to decrease by 40%, which will provide annual budget savings of about 14.3 billion rubles,” the report says.
Furthermore, Avexima plans to produce Russia’s first domestically developed anticoagulant, Dimolegin, on Russky Island, managing the full cycle from substance synthesis to the finished dosage form. A pilot production line for the first Russian antithrombotic drug was commissioned in September; the launch was showcased at the Eastern Economic Forum. In addition, the company plans to conduct clinical trials to expand the indications of Dimolegin.
The Chinese company JiuJien Pacific Biotechnologies will also set up production of a line of cellular, exosomal and biopolymer drugs for cancer therapy and regenerative medicine at the center, while the Russian Biocryogen will process Ahnfeltia algae to produce pharmaceutical-grade agar and agarose.
The construction of the pilot site of the Innovation and Technology Center Russky began in 2024 at the expense of a single presidential subsidy provided through the Ministry for the Development of the Russian Far East. The site spanning 7,600 square meters is set to host no fewer than 50 high-tech projects in the fields of World Ocean research, biomedicine, pharmaceuticals, as well as bio- and information and communication technologies. The total volume of private investments in the projects will exceed 1 billion rubles.
* Reverse engineering is the process of analyzing a finished product to understand its design, functionality, components, or chemical composition.
